+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
1084-65-7,MFCD01863354
Catalog No.:AA0083IF

1084-65-7 | Meticrane

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$7.00   $5.00
- +
25mg
98%
in stock  
$47.00   $33.00
- +
1g
98%
in stock  
$522.00   $366.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0083IF
Chemical Name:
Meticrane
CAS Number:
1084-65-7
Molecular Formula:
C10H13NO4S2
Molecular Weight:
275.3445
MDL Number:
MFCD01863354
SMILES:
Cc1cc2CCCS(=O)(=O)c2cc1S(=O)(=O)N
NSC Number:
759309
Properties
Computed Properties
 
Complexity:
485  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
0.5  

Downstream Synthesis Route
1084-65-7    98-83-9   
6-methyl-7-((2-methyl-2-phenylaziridin-1-yl)sulfonyl)thiochromane1,1-dioxide 

[1]JournaloftheAmericanChemicalSociety,2015,vol.137,p.5638-5641

1084-65-7    98-83-9   
6-methyl-N-(2-methyl-2-phenylhexyl)thiochromane-7-sulfonamide1,1-dioxide 

[1]JournaloftheAmericanChemicalSociety,2015,vol.137,p.5638-5641

1084-65-7   
C12H13NO4S2 

[1]ChemicalScience,2019,vol.10,p.5832-5836

1084-65-7   
C10H11ClO4S2 

[1]ChemicalScience,2019,vol.10,p.5832-5836

[1]Caiger,Lewis;Zhao,Huaibo;Constantin,Timothée;Douglas,JamesJ.;Leonori,Daniele[ACSCatalysis,2023,vol.13,#7,p.4985-4991]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Rumiko TANAKA, et al. Crystal Structure of Meticrane. ANALYTICAL SCIENCES 2007, VOL. 23.

Title: Lesterhuis WJ, et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergisticdrug combinations. Sci Rep. 2015 Jul 21;5:12298.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 1084-65-7
110222-52-1

110222-52-1
Building Blocks
More >
Tags:1084-65-7 Molecular Formula|1084-65-7 MDL|1084-65-7 SMILES|1084-65-7 Meticrane
Catalog No.: AA0083IF
1084-65-7,MFCD01863354
1084-65-7 | Meticrane
Pack Size： 1mg
Purity： 98%
in stock
$7.00 $5.00
Pack Size： 25mg
Purity： 98%
in stock
$47.00 $33.00
Pack Size： 1g
Purity： 98%
in stock
$522.00 $366.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0083IF
Chemical Name: Meticrane
CAS Number: 1084-65-7
Molecular Formula: C10H13NO4S2
Molecular Weight: 275.3445
MDL Number: MFCD01863354
SMILES: Cc1cc2CCCS(=O)(=O)c2cc1S(=O)(=O)N
NSC Number: 759309
Properties
Complexity: 485  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 17  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 1  
XLogP3: 0.5  
Downstream Synthesis Route
1084-65-7    98-83-9   
6-methyl-7-((2-methyl-2-phenylaziridin-1-yl)sulfonyl)thiochromane1,1-dioxide 

[1]JournaloftheAmericanChemicalSociety,2015,vol.137,p.5638-5641

1084-65-7    98-83-9   
6-methyl-N-(2-methyl-2-phenylhexyl)thiochromane-7-sulfonamide1,1-dioxide 

[1]JournaloftheAmericanChemicalSociety,2015,vol.137,p.5638-5641

1084-65-7   
C12H13NO4S2 

[1]ChemicalScience,2019,vol.10,p.5832-5836

1084-65-7   
C10H11ClO4S2 

[1]ChemicalScience,2019,vol.10,p.5832-5836

1084-65-7    301673-14-3    2920866-61-9 

[1]Caiger,Lewis;Zhao,Huaibo;Constantin,Timothée;Douglas,JamesJ.;Leonori,Daniele[ACSCatalysis,2023,vol.13,#7,p.4985-4991]

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Rumiko TANAKA, et al. Crystal Structure of Meticrane. ANALYTICAL SCIENCES 2007, VOL. 23.

Title: Lesterhuis WJ, et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergisticdrug combinations. Sci Rep. 2015 Jul 21;5:12298.

Related Products of of 1084-65-7
110222-52-1
110222-52-1
Building Blocks More >
1077-24-3
1077-24-3
3-(p-Tolylamino)propanenitrile
AA008483 | MFCD00033183
1073-00-3
1073-00-3
Cyclopropaneaceticacid, 2-methylene-
AA0084TG | MFCD11558999
104877-13-6
104877-13-6
2-Naphthalenecarboxylicacid, 3-amino-5,6,7,8-tetrahydro-
AA0085GX | MFCD16876339
103026-83-1
103026-83-1
Dehydro Nisoldipine
AA008630 | MFCD10565997
89035-91-6
89035-91-6
([4-(Trifluoromethyl)benzoyl]amino)acetic acid
AA0087WF | MFCD00176425
887029-70-1
887029-70-1
2-(2-SEC-BUTYLPHENOXY)PROPANOIC ACID
AA0089AW | MFCD08559345
886365-46-4
886365-46-4
5-Chloro-3-methylpyridine-2-carboxylic acid
AA008AG0 | MFCD07375127
885-44-9
885-44-9
5-Chloro-1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazole-4-carbaldehyde
AA008BQY | MFCD05262939
87769-64-0
87769-64-0
2-benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one
AA008D1T | MFCD22493495
873-49-4
873-49-4
Cyclopropylbenzene
AA008E34 | MFCD00001275
Submit
© 2017 AA BLOCKS, INC. All rights reserved.